North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

Press releases published on May 12, 2026

May 12, 2026

MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026

Indeterminate GlobeNewswire

May 12, 2026

Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

Indeterminate GlobeNewswire

May 12, 2026

Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference

Indeterminate GlobeNewswire

May 12, 2026

Compass Therapeutics to Participate in Upcoming May Investor Events

Indeterminate GlobeNewswire

May 12, 2026

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

May 12, 2026

Harvard Bioscience Announces First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 12, 2026

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Indeterminate GlobeNewswire

May 12, 2026

Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

May 12, 2026

CorVel Corporation to Host Live Earnings Release Webcast

Indeterminate GlobeNewswire

May 12, 2026

Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

May 12, 2026

ProQR Announces First Quarter 2026 Operating and Financial Results

Indeterminate GlobeNewswire

May 12, 2026

Immatics Announces First Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

May 12, 2026

NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference

Indeterminate GlobeNewswire

May 12, 2026

Sionna Therapeutics Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 12, 2026

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May

Indeterminate GlobeNewswire

May 12, 2026

Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases

Indeterminate GlobeNewswire

May 12, 2026

Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

May 12, 2026

Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Indeterminate GlobeNewswire

May 12, 2026

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

May 12, 2026

Olema Oncology Reports First Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire